Literature DB >> 8201582

Oral bile acids in cystic fibrosis-associated liver disease.

C Colombo1, A Crosignani, M G Apostolo, M T Marzano, N Bettinardi, A Giunta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8201582      PMCID： PMC1294261     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  25 in total

1.  Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial.

Authors:  L J Smith; F Lacaille; G Lepage; N Ronco; A Lamarre; C C Roy
Journal:  Am J Dis Child       Date:  1991-12

2.  Ursodeoxycholic acid in biliary atresia.

Authors:  H Nittono; A Tokita; M Hayashi; N Nakatsu; K Obinata; T Watanabe; Y Yamashiro; K Yabuta; T Miyano
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

3.  Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid.

Authors:  W Vogel; H Kathrein; G Judmaier; H Braunsteiner
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

4.  Ursodeoxycholic acid for primary biliary cirrhosis.

Authors:  A F Hofmann; H Popper
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

5.  Liver disease and common-bile-duct stenosis in cystic fibrosis.

Authors:  K J Gaskin; D L Waters; R Howman-Giles; M de Silva; J W Earl; H C Martin; A E Kan; J M Brown; S F Dorney
Journal:  N Engl J Med       Date:  1988-02-11       Impact factor: 91.245

6.  Excessive fecal taurine loss predisposes to taurine deficiency in cystic fibrosis.

Authors:  G N Thompson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

7.  Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology.

Authors:  N Graham; A R Manhire; R J Stead; W R Lees; M E Hodson; J C Batten
Journal:  Clin Radiol       Date:  1985-03       Impact factor: 2.350

8.  Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis.

Authors:  C Maurage; C Lenaerts; A Weber; P Brochu; I Yousef; C C Roy
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-07       Impact factor: 2.839

9.  Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts.

Authors:  C C Roy; A M Weber; C L Morin; G Lepage; G Brisson; I Yousef; R Lasalle
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

10.  Epidemiology of ulcerative colitis in western Norway.

Authors:  K Haug; E Schrumpf; S Barstad; G Fluge; J F Halvorsen
Journal:  Scand J Gastroenterol       Date:  1988-06       Impact factor: 2.423
View more
  1 in total

Review 1.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.